Washington — The US Food and Drug Administration announced its plans for a potential rule aiming to reduce addictiveness of cigarettes and other combusted tobacco products, mainly in youth.
The proposed rule, part of the Biden-Harris Administration’s plans for future potential regulatory actions, would establish a maximum level of nicotine in cigarettes with the goal of reducing youth use, addiction, and death.
According to the agency, nicotine makes it very hard to quit smoking as addiction to nicotine in combusted products is the main driver of sustained use of these products.
FDA Commissioner Robert Califf stated, citing the US surgeon general, that 87% of adult smokers start smoking before age 18, and about two-thirds of adult daily smokers begin smoking daily by 18 years of age.
The FDA noted that tobacco use is the major cause of preventable disease and death in the United States with 480,000 people die prematurely each year from a smoking-attributed disease.
Also, tobacco use costs nearly $300 billion a year in direct health care and lost productivity.
As per an earlier FDA paper, by year 2100, a potential nicotine product standard could result in more than 33 million people not becoming regular smokers, a smoking rate of only 1.4%, compared to the current smoking rate of 12.5%.
More than 8 million fewer people are also expected to die from tobacco-related illnesses.
So far, the FDA has taken action on around 99% of the nearly 6.7 million products for which applications were received by September 9, 2020.
The agency issued marketing denial orders for more than 1 million electronic nicotine delivery system (ENDS) products.
The agency has conducted previous youth e-cigarette prevention campaigns, and conducted various enforcement actions against tobacco manufacturers, retailers, importers and distributors.
The FDA in early June launched “Next Legends” Youth E-cigarette Prevention Campaign, aiming to protect American Indian/Alaska Native youth, ages 12-17, from the harms of vaping through culturally specific ads.
At present, the FDA restricts youth access to tobacco products by requiring retailers to check ID prior to sale and not sell to anyone under the age of 21.
©2022 dpa GmbH. Distributed by Tribune Content Agency, LLC.